Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Administration Timing of G-CSF on CD34+ Cell Mobilization in Healthy Donors
NCT07423728Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Nov 2026
- Primary completion
- Mar 2027
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised, open-label trial of filgrastim (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Peripheral Blood CD34+ Cell Count. Started Nov 2026; status: recruiting.
02
Drugs
filgrastim
Beyond the preview
Go deeper on NCT07423728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423728.